PharmaBoardroom

Interview with Tapani Sura, General Manager, Astellas Poland

You were appointed general manager of Astellas Poland in early 2006, only a bit after Astellas Pharma Inc. was established, on April 1, 2005 through…

Interview with Peter Koetsier, General Manager, Bristol-Myers…

As Squibb Corporation and Bristol-Myers merged in 1989, Bristol-Myers Squibb has been officially operating in this market since that date, but the…

Interview with Mauricio Rosas, Director Pharmaceutical Division,…

What have been Merck’s major milestones and achievements for its pharmaceutical division since you took the reins? I have been managing the…

Interview with Carlos Kiffer, President, GC-2

As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up to…

Interview with Christian Bechon, Chairman & CEO, LFB

In the wake of the most recent CSIS meeting, LFB and Sanofi-Aventis announced the intention to collaborate in bioproduction. What are the terms to…

Interview with Tamàs Dàvid, Deputy Director & Market…

With various new government measures, the pharmaceutical and healthcare sector in Hungary has been undergoing quite a turbulent period recently. But…

Interview with Stephen Merrick, President, Bristol-Myers Squibb…

Two days ago, the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming…

Interview with Xander Bos, General Manager, Boehringer Ingelheim…

While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general…

Interview with Imanda Wapenaar, Executive Director, WestHolland…

WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week…

Interview with Maria Del Pilar Muñoz, Director of Sustainability…

Your position unites two somewhat incongruous titles – Director of Sustainability, and New Business. How did this come to be, and what if any…

Interview with Sebastiano Castorina, CEO, Takeda Italy

Takeda has more than 25 years of history in Italy and reached the 20th position in the Italian market- a striking performance in a context when it is…

Interview with Ewe Kheng Huat, Managing Director, Merck Sharp…

Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…

Tagged with